These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11335786)

  • 1. A new prodrug of paclitaxel: synthesis of Protaxel.
    Seligson AL; Terry RC; Bressi JC; Douglass JG; Sovak M
    Anticancer Drugs; 2001 Apr; 12(4):305-13. PubMed ID: 11335786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and preclinical characterization of a paclitaxel prodrug with improved antitumor activity and water solubility.
    Niethammer A; Gaedicke G; Lode HN; Wrasidlo W
    Bioconjug Chem; 2001; 12(3):414-20. PubMed ID: 11353540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of 2'-carbamate-linked and 2'-carbonate-linked prodrugs of paclitaxel: selective activation by the tumor-associated protease plasmin.
    de Groot FM; van Berkom LW; Scheeren HW
    J Med Chem; 2000 Aug; 43(16):3093-102. PubMed ID: 10956217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of water-soluble paclitaxel prodrugs.
    Feng X; Yuan YJ; Wu JC
    Bioorg Med Chem Lett; 2002 Nov; 12(22):3301-3. PubMed ID: 12392737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-tumor efficacy of 3-(2-Nitrophenyl) propionic acid-paclitaxel (NPPA-PTX): a novel paclitaxel bioreductive prodrug.
    Song P; Yao X; Zhong T; Zhang S; Guo Y; Ren W; Huang D; Duan XC; Yin YF; Zhang SS; Zhang X
    Oncotarget; 2016 Jul; 7(30):48467-48480. PubMed ID: 27366947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Taxol (paclitaxel) prodrugs designed for ADEPT and PMT strategies in cancer chemotherapy.
    Alaoui AE; Saha N; Schmidt F; Monneret C; Florent JC
    Bioorg Med Chem; 2006 Jul; 14(14):5012-9. PubMed ID: 16554162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel.
    Meerum Terwogt JM; ten Bokkel Huinink WW; Schellens JH; Schot M; Mandjes IA; Zurlo MG; Rocchetti M; Rosing H; Koopman FJ; Beijnen JH
    Anticancer Drugs; 2001 Apr; 12(4):315-23. PubMed ID: 11335787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-paclitaxel conjugates as drug delivery system: synthesis, self-assembly property, drug release, and antitumor activity.
    Wang Y; Xin D; Liu K; Zhu M; Xiang J
    Bioconjug Chem; 2009 Dec; 20(12):2214-21. PubMed ID: 19950889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel approach of water-soluble paclitaxel prodrug with no auxiliary and no byproduct: design and synthesis of isotaxel.
    Hayashi Y; Skwarczynski M; Hamada Y; Sohma Y; Kimura T; Kiso Y
    J Med Chem; 2003 Aug; 46(18):3782-4. PubMed ID: 12930140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel taxane with improved tolerability and therapeutic activity in a panel of human tumor xenografts.
    Polizzi D; Pratesi G; Tortoreto M; Supino R; Riva A; Bombardelli E; Zunino F
    Cancer Res; 1999 Mar; 59(5):1036-40. PubMed ID: 10070960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of taxoids 5. Synthesis and evaluation of novel water-soluble prodrugs of a 3'-desphenyl-3'-cyclopropyl analogue of docetaxel.
    Yamaguchi T; Harada N; Ozaki K; Arakawa H; Oda K; Nakanishi N; Tsujihara K; Hashiyama T
    Bioorg Med Chem Lett; 1999 Jun; 9(12):1639-44. PubMed ID: 10397492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo.
    Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R
    Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma.
    Rango E; D'Antona L; Iovenitti G; Brai A; Mancini A; Zamperini C; Trivisani CI; Marianelli S; Fallacara AL; Molinari A; Cianciusi A; Schenone S; Perrotti N; Dreassi E; Botta M
    Eur J Med Chem; 2021 Nov; 223():113653. PubMed ID: 34161866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical oral antitumor activity of BMS-185660, a paclitaxel derivative.
    Rose WC; Lee FY; Golik J; Kadow J
    Cancer Chemother Pharmacol; 2000; 46(3):246-50. PubMed ID: 11021743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug delivery systems: water soluble taxol 2'-poly(ethylene glycol) ester prodrugs-design and in vivo effectiveness.
    Greenwald RB; Gilbert CW; Pendri A; Conover CD; Xia J; Martinez A
    J Med Chem; 1996 Jan; 39(2):424-31. PubMed ID: 8558510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase.
    Sirotnak FM; Zakowski MF; Miller VA; Scher HI; Kris MG
    Clin Cancer Res; 2000 Dec; 6(12):4885-92. PubMed ID: 11156248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrolyzable hydrophobic taxanes: synthesis and anti-cancer activities.
    Ali S; Ahmad I; Peters A; Masters G; Minchey S; Janoff A; Mayhew E
    Anticancer Drugs; 2001 Feb; 12(2):117-28. PubMed ID: 11261884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel prodrug of paclitaxel that is cleaved by prostate-specific antigen: an in vitro and in vivo evaluation study.
    Elsadek B; Graeser R; Esser N; Schäfer-Obodozie C; Abu Ajaj K; Unger C; Warnecke A; Saleem T; El-Melegy N; Madkor H; Kratz F
    Eur J Cancer; 2010 Dec; 46(18):3434-44. PubMed ID: 20933385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor efficacy of taxane liposomes on a human ovarian tumor xenograft in nude athymic mice.
    Sharma A; Straubinger RM; Ojima I; Bernacki RJ
    J Pharm Sci; 1995 Dec; 84(12):1400-4. PubMed ID: 8748320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microtubule-stabilizing marine metabolite laulimalide and its derivatives: synthetic approaches and antitumor activity.
    Mulzer J; Ohler E
    Chem Rev; 2003 Sep; 103(9):3753-86. PubMed ID: 12964883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.